Kouprina N, Ebersole T, Koriabine M, Pak E, Rogozin I B, Katoh M, Oshimura M, Ogi K, Peredelchuk M, Solomon G, Brown W, Barrett J C, Larionov V
Laboratory of Biosystems and Cancer, Center for Cancer Research, National Cancer Institute, NIH, Building 37, Room 5032, Bethesda, MD 20892, USA.
Nucleic Acids Res. 2003 Feb 1;31(3):922-34. doi: 10.1093/nar/gkg182.
Human centromeres remain poorly characterized regions of the human genome despite their importance for the maintenance of chromosomes. In part this is due to the difficulty of cloning of highly repetitive DNA fragments and distinguishing chromosome-specific clones in a genomic library. In this work we report the highly selective isolation of human centromeric DNA using transformation-associated recombination (TAR) cloning. A TAR vector with alphoid DNA monomers as targeting sequences was used to isolate large centromeric regions of human chromosomes 2, 5, 8, 11, 15, 19, 21 and 22 from human cells as well as monochromosomal hybrid cells. The alphoid DNA array was also isolated from the 12 Mb human mini-chromosome DeltaYq74 that contained the minimum amount of alphoid DNA required for proper chromosome segregation. Preliminary results of the structural analyses of different centromeres are reported in this paper. The ability of the cloned human centromeric regions to support human artificial chromosome (HAC) formation was assessed by transfection into human HT1080 cells. Centromeric clones from DeltaYq74 did not support the formation of HACs, indicating that the requirements for the existence of a functional centromere on an endogenous chromosome and those for forming a de novo centromere may be distinct. A construct with an alphoid DNA array from chromosome 22 with no detectable CENP-B motifs formed mitotically stable HACs in the absence of drug selection without detectable acquisition of host DNAs. In summary, our results demonstrated that TAR cloning is a useful tool for investigating human centromere organization and the structural requirements for formation of HAC vectors that might have a potential for therapeutic applications.
尽管人类着丝粒对于染色体的维持至关重要,但它仍然是人类基因组中特征描述不佳的区域。部分原因在于克隆高度重复的DNA片段以及在基因组文库中区分染色体特异性克隆存在困难。在这项工作中,我们报告了使用转化相关重组(TAR)克隆技术高度选择性地分离人类着丝粒DNA。一个以α卫星DNA单体作为靶向序列的TAR载体被用于从人类细胞以及单染色体杂交细胞中分离人类染色体2、5、8、11、15、19、21和22的大型着丝粒区域。还从包含正确染色体分离所需最小量α卫星DNA的12 Mb人类小染色体DeltaYq74中分离出了α卫星DNA阵列。本文报道了不同着丝粒结构分析的初步结果。通过转染到人HT1080细胞中评估克隆的人类着丝粒区域支持人类人工染色体(HAC)形成的能力。来自DeltaYq74的着丝粒克隆不支持HAC的形成,这表明内源性染色体上功能性着丝粒存在的要求与从头形成着丝粒的要求可能不同。一个来自22号染色体且没有可检测到的CENP - B基序的α卫星DNA阵列构建体在没有药物选择且没有可检测到的宿主DNA获取的情况下形成了有丝分裂稳定的HAC。总之,我们的结果表明TAR克隆是研究人类着丝粒组织以及形成可能具有治疗应用潜力的HAC载体的结构要求的有用工具。